ComASP® Benzylpenicillin 0.002-32 is an in vitro diagnostic product for antimicrobial susceptibility testing (AST)
of clinical isolates based on growth of the test organism in the presence of various concentrations of an
This ComASP® system is used for quantitative determination of the minimum inhibitory concentration (MIC) of
benzylpenicillin against Streptococcus pneumoniae.
75011_PI ComASP benzylpenicillin panel-EWC